Cargando…
P1272: GP130/STAT3 AXIS IS A POTENTIAL THERAPEUTIC TARGET FOR HISTONE DEACETYLASE INHIBITOR-RESISTANT CUTANEOUS T-CELL LYMPHOMA
Autores principales: | Takahashi, Y., Kitadate, A., Ikeda, S., Iwama, S., Abe, K., Matsuda, Y., Tagawa, H., Wakui, H., Takahashi, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429465/ http://dx.doi.org/10.1097/01.HS9.0000847952.99146.35 |
Ejemplares similares
-
Downregulation of miR‐26 promotes invasion and metastasis via targeting interleukin‐22 in cutaneous T‐cell lymphoma
por: Matsuda, Yuka, et al.
Publicado: (2022) -
Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma
por: Abe, Fumito, et al.
Publicado: (2016) -
Histone deacetylase inhibitors downregulate CCR4 expression and decrease mogamulizumab efficacy in CCR4-positive mature T-cell lymphomas
por: Kitadate, Akihiro, et al.
Publicado: (2018) -
Hypoxia‐inducible hexokinase‐2 enhances anti‐apoptotic function via activating autophagy in multiple myeloma
por: Ikeda, Sho, et al.
Publicado: (2020) -
Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma
por: Ikeda, Sho, et al.
Publicado: (2016)